![](/img/cover-not-exists.png)
Malignant, benign conventional and regulatory T immune compartments in 36 patients treated with mogamulizumab for advanced CTCL
Roelens, M., de Masson, A., Battistella, M., Mourah, S., Estevez, M.J., Delyon, J., Herms, F., Ram-Wolff, C., Lebbé, C., Bagot, M., Moins-Teisserenc, H.Volume:
119
Year:
2019
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(19)30522-2
File:
PDF, 195 KB
english, 2019